The recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc. WASHINGTON: Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in ... Economic Times, 1 week ago
Cadila Healthcare recalls anti-hypertension drug in US - Hindu Business Line, 1 week ago
Cadila recalls drug in US - Calcutta Telegraph, 6 days ago
1 images for "zydus cadila"
Firstcall Research report on Cadila Healthcare Zydus Cadila, a global healthcare provider was founded by Late Mr. Ramanbhai B. Patel in 1952. In 1995, the group restructured its operations and emerged with a new identity under the aegis of Zydus ...Moneycontrol.com, 3 weeks ago Zydus gets USFDA nod to market anti-diabetic tablets; closes down 1.15% India Infoline, 1 month ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod Money Control, 1 month ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets Indian-Commodity, 1 month ago
Zydus Cadila COO and executive director Ganesh Nayak on how skeet shooting helps him keep his eyes trained on business goals Growing up in Bombay, Ganesh Nayak spent all his free time reading the iconic Phantom comic series, fascinated by the Lee Falk-created ...Outlook, 2 weeks ago
Cadila Healthcare Ltd (Zydus Cadila) on Monday said it has been granted generic licence by Gilead Sciences Inc, to manufacture breakthrough treatment of Hepatitis C. The two companies have entered into a generic, non-exclusive licensing agreement ...Hindu Business Line, 1 month ago Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C Equity Bulls, 1 month ago Zydus inks pact with Gilead Sciences to produce and distribute Hepatitis C drug Indian-Commodity, 1 month ago Zydus granted license to produce generic hepatitis C drug Smart Investor, 1 month ago
With an eye on the growing biologics market, Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to mark its presence in the segment. The company plans to launch one to three products by next year, and hopes to have a portfolio ...Business Standard India, 2 weeks ago Zydus Cadila bags license for hepatitis C drug Business Standard, 1 month ago
Homegrown drug major Zydus Cadila has set a target of clocking a consolidated turnover of over Rs 10,000 crore by FY'16. "We will have a revenue of Rs 10,000 crore in FY16. We closed last fiscal with a revenue of Rs 7,208 crore," Zydus Cadila Chief ...The Echo Of India, 1 month ago Zydus Wellness : CADILA SETS SALES TARGET OF Rs10,000 CRORE 4 Traders, 1 month ago Zydus Cadila sets Rs 10,000 cr sales target by FY16 Business Standard, 1 month ago Zydus Cadila Targets Rs 10,000 Crore Sales by FY16 NDTV, 1 month ago
Speaking at the launch, Mr Ganesh Nayak, ED and COO, Zydus Cadila, said, The idea of this cause campaign stemmed from the insight that while a large proportion of India had excess calorie consumption leading to a state of unhealthiness or weight ...Web Newswire, 1 month ago Zydus wellness ties up with NGO Donate Your Calories to help nourish children campaign India Retailing, 1 month ago Zydus Wellness : Akshay Kumar unveiled the 'Donate Your Calories To Help Nourish Children' campaign in Mumbai 4 Traders, 1 month ago 'Donate Your Calories' says Sugar Free Agencyfaqs!, 1 month ago
More from: , Express Pharma...and 1 other sources
Ahmedabad-based Cadila Healthcare Ltd (Zydus Cadila) is facing lawsuits in US court, including that filed by global pharma major Novartis Pharmaceuticals, for infringement of patents. Novartis has filed two suits against Cadila Healthcare's US ...Business Standard India, 1 month ago
, Zydus Cadila reported sales of Rs. 2057 crore, up by 25% from Rs. 1646 crore in the corresponding quarter of the previous year on a consolidated basis. The net profit is up by 23% to Rs. 240 crore from Rs. 195 crore in the first quarter of ...Noodls, 2 months ago CADILA HEALTHCARE : Zydus Cadila Q1 Net profit up by 23% 4 Traders, 2 months ago Zydus Cadila Q1 net up 23% Business Standard, 2 months ago
Boston, MA -- (SBWIRE) -- 08/28/2014 -- Zydus Cadila Healthcare Limited - Product Pipeline ReviewSearchBug, 1 month ago Biocon : Market Report, "Biocon Limited - Product Pipeline Review - 2014", published 4 Traders, 1 month ago
on your WebpageAdd Widget >Get your members hooked!